These findings support further evaluation of GLIS3 as a biomarker for risk stratification and provide a rationale for biomarker-guided targeting of the GLIS3-TGFBR3-Hedgehog axis in STAD. Here, TGFBR3 is linked to gastric adenocarcinoma.